Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02106819 · ClinicalTrials.gov registry record
Emotional Communication Disorders in Cerebellar Disease
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 56
- Enrollment target
NCT02106819: Completed study, sponsored by University of Florida.
NCT02106819 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02106819 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
Study Summary
The cerebellum has been linked to cognitive and emotional functions and there is increasing evidence that damage to posterior portions of the cerebellum can result in frontal-executive, visuospatial, and verbal deficits, including dysprosodia, and affective changes including blunting of affect or disinhibited and inappropriate behavior. Based on preliminary clinical observations and tests performed in the investigator's clinic, disorders of emotional communication may also be associated with cerebellar dysfunction. Emotional communication includes the production and comprehension of facial and prosodic expressions and is critical to maintaining positive and supportive relationships. Deficits in emotional communication can have devastating effects on relationships and on quality of life for those affected. Although deficits in affect and prosody have been reported in association with posterior cerebellar disorders, there are currently no studies systematically investigating emotional communication in individuals with cerebellar dysfunction. It is known that the cerebellum has strong connections with the cerebral cortex, especially the frontal lobes, and that cortical damage from stroke or neurodegenerative disease can result in disorders of emotional communication. Impairments in the integrity of cerebellar-cerebral networks from cerebellar disease may produce similar deficits in emotional communication. The purpose of this study is to systematically investigate and describe deficits in emotional communication in a series of patients with cerebellar disease. Participants will be individuals diagnosed with posterior cerebellar degeneration or damage from a non-hemorrhagic infarction, and age-matched neurologically healthy controls. Assessment will include a battery of tests of neuropsychological function as well as tests of emotional communication. Comprehension of emotional facial and prosodic expressions will be assessed as well as production of emotional communicat
Primary Outcome
Comprehension of emotional facial and prosodic expressions assessed via identification, discrimination and matching tasks.
Interventions
- BEHAVIORAL Testing of emotional communication ability
- PROCEDURE magnetic resonance imaging (MRI) of the brain
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-12-31 |
What the finished NCT02106819 record still lists
NCT02106819 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 56 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Testing of emotional communication ability is the first listed.
NCT02106819 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02106819 about?
NCT02106819 is a clinical study titled "Emotional Communication Disorders in Cerebellar Disease". The cerebellum has been linked to cognitive and emotional functions and there is increasing evidence that damage to posterior portions of the cerebellum can result in frontal-executive, visuospatial, and verbal deficits, including dysprosodia, and affective changes including blunting of affect or di...
What is the current status of trial NCT02106819?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2014-04. Estimated completion is 2016-12-31.
What interventions are being tested in trial NCT02106819?
The interventions under investigation include: Testing of emotional communication ability (BEHAVIORAL), magnetic resonance imaging (MRI) of the brain (PROCEDURE).
Who is sponsoring clinical trial NCT02106819?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia